SCHEMBL8937206

SCHEMBL8937206

Oc1ccc(CC(O)CN2CCC(c3ccccc3)CC2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
SLC18A3 Q16572 4/20 0.79
GRIN2D O15399 3/20 0.70
GRIN3B O60391 3/20 0.70
ADRA1D P25100 3/20 0.70
ADRA1A P35348 3/20 0.70
ADRA1B P35368 3/20 0.70
GRIN1 Q05586 3/20 0.70
GRIN2A Q12879 3/20 0.70
GRIN2B Q13224 3/20 0.70
GRIN2C Q14957 3/20 0.70
GRIN3A Q8TCU5 3/20 0.70
SIGMAR1 Q99720 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7544920 0.88 SLC18A3 (0.77) SLC18A3GRIN2DGRIN3BADRA1DADRA1A
SCHEMBL8736183 0.88 SLC18A3 (1.00) SLC18A3GRIN2DGRIN3BADRA1DADRA1A
SCHEMBL8734798 0.86 SLC18A3 (0.66) SLC18A3GRIN2DGRIN3BADRA1DADRA1A
SCHEMBL9483295 0.85 SLC18A3 (0.58) SLC18A3GRIN2DGRIN3BADRA1DADRA1A
SCHEMBL8734239 0.85 SLC18A3 (0.72) SLC18A3GRIN2DGRIN3BADRA1DADRA1A
SCHEMBL8734718 0.83 SLC18A3 (0.70) SLC18A3GRIN2DGRIN3BADRA1DADRA1A
SCHEMBL8734255 0.80 SLC18A3 (0.76) SLC18A3GRIN2DGRIN3BADRA1DADRA1A
SCHEMBL9341163 0.80 SLC18A3 (0.65) SLC18A3GRIN2DGRIN3BADRA1DADRA1A
SCHEMBL8736833 0.79 SLC18A3 (0.64) SLC18A3GRIN2DGRIN3BADRA1DADRA1A
SCHEMBL9159777 0.79 SLC18A3 (0.73) SLC18A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0576611-A4 RADIOPHARMACEUTICAL AGENTS FOR THE DETECTION OF ALZHEIMER'S DISEASE UNIV MINNESOTA (US) 1996-01-24 EP disclosed
US-5358712-A For binding to receptors when monitoring for cholinergic innervation in living brains, detection of Alzheimer*s disease REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 1994-10-25 US disclosed
EP-0576611-A1 RADIOPHARMACEUTICAL AGENTS FOR THE DETECTION OF ALZHEIMER'S DISEASE THE REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 1994-01-05 EP disclosed
WO-1992016239-A1 RADIOPHARMACEUTICAL AGENTS FOR THE DETECTION OF ALZHEIMER'S DISEASE THE REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 1992-10-01 WO disclosed